GlassScriptPhysician profile
Amar J Thosani
NPI 1063695591
$96,911.40
in general payments reported to CMS, 2019-2025
30 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2020: $5,836 · 2021: $23K · 2022: $9,947 · 2023: $16K · 2024: $11K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,840 · Travel and Lodging: $2,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,460.00 |
| Food and Beverage | $15,771.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,662.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,840.00 |
| Travel and Lodging | $2,672.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32,440.55 | 2019-2025 | General - Therapies, Orbera Intragastric Balloon System, Spyglass |
| Endogastric Solutions, INC | $26,906.37 | 2019-2024 | Esophyx |
| Merit Medical Systems INC | $21,825.98 | 2021-2025 | Esophyx, Endomaxx Stent and Delivery System, Esophageal Stent/Delivery System |
| Conmed Corporation | $9,301.48 | 2020-2025 | Conmed Biliary, Conmed Generators, Conmed Hemostasis |
| Apollo Endosurgery US INC | $1,270.70 | 2023 | Overstitch Endoscopic Suturing System |
| Olympus Medical Systems Corporation | $880.00 | 2025 | |
| Olympus America INC. | $682.25 | 2019-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope, Evis X1 Video System Center |
| Genzyme Corporation | $351.48 | 2023-2025 | |
| Steris Corporation | $344.45 | 2023-2025 | |
| Creo Medical INC. | $338.74 | 2022-2023 | Speedboat |
| Lumendi LLC | $281.47 | 2019-2024 | |
| Cook Medical LLC | $269.90 | 2022 | |
| Ambu INC. | $235.18 | 2020-2021 | |
| Fujifilm Healthcare Americas Corporation | $222.22 | 2025 | |
| Medtronic, INC. | $212.44 | 2021-2024 | Bravo |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $196.14 | 2022-2025 | Dupixent |
| Viewray Technologies INC | $188.75 | 2021 | |
| Omega Medical Imaging, LLC | $126.35 | 2022-2025 | |
| Olympus Corporation of The Americas | $117.24 | 2025 | |
| Intuitive Surgical, INC. | $116.76 | 2025 | |
| Dova Pharmaceuticals | $112.92 | 2019 | |
| Axonics, INC. | $112.75 | 2023 | Axonics, Bulkamid |
| Elekta, INC. | $100.18 | 2020 | |
| Abbvie INC. | $62.05 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $59.09 | 2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.66 | 2019 | |
| Covidien LP | $50.25 | 2019 | |
| Erbe USA INC | $23.86 | 2019 | |
| Horizon Therapeutics Plc | $19.46 | 2019 | |
| Echosens North America, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Thosani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.